Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization

被引:41
作者
Doan, T. V. P. [1 ,2 ]
Olivier, J. C. [1 ,2 ]
机构
[1] Univ Poitiers, Fac Med Pharm, F-86000 Poitiers, France
[2] INSERM, ERI 23, F-86000 Poitiers, France
关键词
PLGA; Microspheres; SPG membrane; Premix membrane emulsification; Rifampicin; MULTIPLE EMULSIONS; EMULSIFICATION; TUBERCULOSIS; ANTIBIOTICS; FORMULATION; INHALATION; DROPLETS; SIZE;
D O I
10.1016/j.ijpharm.2009.08.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The water-in-oil solvent evaporation method with premix membrane homogenization was investigated to improve productivity of the preparation of narrowly size-distributed poly(lactide-co-glycolide) (PLGA) microspheres for rifampicin lung delivery as dry aerosols. Using ethyl acetate as organic solvent, a coarse oil-in-water emulsion (or premix) was prepared under magnetic stirring and homogenized by extrusion through a Shirasu porous glass (SPG) membrane (5.9 mu m porosity). Microspheres were obtained after dilution and solvent evaporation. Formulation parameters investigated were: PLGA concentration, transmembrane pressure and oil:water volume ratio. The optimal formulation parameters were then applied to prepare rifampicin-loaded microspheres. Loaded microspheres were 1.72 +/- 0.16 mu m in diameter with a span of 0.86 +/- 0.04 and a rifampicin content of 52 +/- 6 mu g/mg microspheres. Release studies in phosphate-buffered saline showed a linear release profile with 40% rifampicin release over 4.5 days. The MMAD of 2.63 mu m of freeze-dried microspheres should be suitable for aerosol administration and delivery into the rat lungs by intratracheal insufflation. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:61 / 66
页数:6
相关论文
共 20 条
[1]   Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats [J].
Bosquillon, C ;
Prat, W ;
Vanbever, R .
JOURNAL OF CONTROLLED RELEASE, 2004, 96 (02) :233-244
[2]   Aerosol antibiotics: considerations in pharmacological and clinical evaluation [J].
Dudley, Michael N. ;
Loutit, Jeff ;
Griffith, David C. .
CURRENT OPINION IN BIOTECHNOLOGY, 2008, 19 (06) :637-643
[3]   Study of types and mixture ratio of organic solvent used to dissolve polymers for preparation of drug-containing PLGA microspheres [J].
Ito, Fuminori ;
Fujimori, Hiroyuki ;
Honnami, Hiroyuki ;
Kawakami, Hiroyoshi ;
Kanamura, Kiyoshi ;
Makino, Kimiko .
EUROPEAN POLYMER JOURNAL, 2009, 45 (03) :658-667
[4]   Re-coalescence of emulsion droplets during high-energy emulsification [J].
Jafari, Seid Mahdi ;
Assadpoor, Elham ;
He, Yinghe ;
Bhandari, Bhesh .
FOOD HYDROCOLLOIDS, 2008, 22 (07) :1191-1202
[5]   Dry powder inhalation of antibiotics in cystic fibrosis therapy:: part 2 Inhalation of a novel colistin dry powder formulation:: a feasibility study in healthy volunteers and patients [J].
Le Brun, PPH ;
de Boer, AH ;
Mannes, GPM ;
de Fraîture, DMI ;
Brimicombe, RW ;
Touw, DJ ;
Vinks, AA ;
Frijlink, HW ;
Heijerman, HGM .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2002, 54 (01) :25-32
[6]   Preparation of uniform poly(lactide) microspheres by employing the Shirasu Porous Glass ( SPG) emulsification technique [J].
Ma, GH ;
Nagai, M ;
Omi, S .
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 1999, 153 (1-3) :383-394
[7]   Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicin [J].
Makino, K ;
Nakajima, T ;
Shikamura, M ;
Ito, F ;
Ando, S ;
Kochi, C ;
Inagawa, H ;
Soma, GI ;
Terada, H .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2004, 36 (01) :35-42
[8]   Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: Manufacture and characterization [J].
O'Hara, P ;
Hickey, AJ .
PHARMACEUTICAL RESEARCH, 2000, 17 (08) :955-961
[9]   Microencapsulation techniques using ethyl acetate as a dispersed solvent: Effects of its extraction rate on the characteristics of PLGA microspheres [J].
Sah, H .
JOURNAL OF CONTROLLED RELEASE, 1997, 47 (03) :233-245
[10]   Respirable microspheres for inhalation - The potential of manipulating pulmonary disposition for improved therapeutic efficacy [J].
Sakagami, M ;
Byron, PR .
CLINICAL PHARMACOKINETICS, 2005, 44 (03) :263-277